tiprankstipranks
Trending News
More News >

Charles Homcy Insider Profile

4 Followers
Charles Homcy, Former Director at Portola Pharma, holds 297.87K shares in Portola Pharma (Ticker: PTLA), holds ― shares in MyoKardia (Ticker: MYOK), holds 37.05K shares in Maze Therapeutics, Inc. (Ticker: MAZE).
tipranks
Charles Homcy

Charles Homcy
Portola Pharma (PTLA)
Former Director

Ranked #72,798 out of 104,104 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-24.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$58M
98.05%
1.83%
0.12%
0.00%
0.00% Others
A breakdown of Charles Homcy's holdings

Insider Roles

BridgeBio Pharma
(BBIO)
Director
Maze Therapeutics, Inc.
(MAZE)
Director
Geron
(GERN)
Director
Pliant Therapeutics
(PLRX)
Director
+1 other positions
Roles that Charles Homcy holds in companies

Most Profitable Insider Trade

Stock:
Global Blood Therapeutics
(GBT)
Rating:Informative Sell
Date:Oct 27, 2017 - Oct 27, 2018
Return:-4.50%
The most profitable trade made by Charles Homcy

Charles Homcy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PTLA
Portola Pharma
Jun 08, 2018
Uninformative Buy
$5.37M
MYOK
MyoKardia
GBT
Global Blood Therapeutics
Oct 27, 2017
Informative Sell
2.38M
$4.75M
BridgeBio Pharma
Aug 12, 2025
Director
Uninformative Sell
13.91M
$56.65M
Pliant Therapeutics
Director
Maze Therapeutics, Inc.
Oct 27, 2025
Director
Uninformative Sell
$1.06M
Geron
May 13, 2011
Director
Uninformative Buy
$67.14K
Cytokinetics
Director
$0.00
List of latest transactions for each holding click on a transaction to see Charles Homcy's performance on stock

Charles Homcy insider profile FAQ

What is the percentage of profitable transactions made by Charles Homcy?
The percentage of profitable transactions made by Charles Homcy is 0%.
    What is the average return per transaction made by Charles Homcy?
    The average return per transaction made by Charles Homcy is -24.10%.
      What stocks does Charles Homcy hold?
      Charles Homcy holds: PTLA, MYOK, GBT, BBIO, PLRX, MAZE, GERN, CYTK stocks.
        What was Charles Homcy’s latest transaction?
        Charles Homcy latest transaction was an Uninformative Buy of ―.
          What was Charles Homcy's most profitable transaction?
          Charles Homcy’s most profitable transaction was an Informative Sell of GBT stock on October 27, 2017. The return on the trade was -4.50%.
            What is Charles Homcy's role in Portola Pharma?
            Charles Homcy's role in Portola Pharma is Former Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.